Synaptic abnormalities are a cardinal feature of Alzheimer's disease (AD) that are known to
arise as the disease progresses. A growing body of evidence suggests that pathological …

Neuroinflammation is a physiological protective response in the context of infection and
injury. However, neuroinflammation, especially if chronic, may also drive …

“The 2022 Hormone Therapy Position Statement of The North American Menopause
Society”(NAMS) updates “The 2017 Hormone Therapy Position Statement of The North …

Key Clinical Points Hormone Therapy for Postmenopausal Women Women younger than 60
years of age or within 10 years after the onset of menopause who have symptomatic …

Estrogens are the hormones of reproduction in women as well as of many other important
functions in the male and female body. They undergo significant changes in the different …

Menopause hormone therapy (MHT) is the most efficient treatment for symptoms of acute
climacteric syndrome and for efficient prevention of long-term estrogen deficiency. Vaginal …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that accounts for
more than half of all dementia cases in the elderly. Interestingly, the clinical manifestations of …

A severe impairment of cognitive function characterizes dementia. Mild cognitive impairment
represents a transition between normal cognition and dementia. The frequency of cognitive …

Introduction Despite a large preclinical literature demonstrating neuroprotective effects of
estrogen, use of menopausal hormone therapy (HT) for Alzheimer's disease (AD) risk …

Abstract The 2017 Hormone Therapy Position Statement of The North American Menopause
Society (NAMS) updates the 2012 Hormone Therapy Position Statement of The North …